ATE307904T1 - Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit - Google Patents

Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit

Info

Publication number
ATE307904T1
ATE307904T1 AT00991290T AT00991290T ATE307904T1 AT E307904 T1 ATE307904 T1 AT E307904T1 AT 00991290 T AT00991290 T AT 00991290T AT 00991290 T AT00991290 T AT 00991290T AT E307904 T1 ATE307904 T1 AT E307904T1
Authority
AT
Austria
Prior art keywords
lsf
lbp
disease
alzheimer
relationship
Prior art date
Application number
AT00991290T
Other languages
English (en)
Inventor
Marie-Christin Chartier-Harlin
Philippe Amouyel
Jean-Charles Lambert
Louise Araria
Original Assignee
Pasteur Institut
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Institut, Inst Nat Sante Rech Med filed Critical Pasteur Institut
Application granted granted Critical
Publication of ATE307904T1 publication Critical patent/ATE307904T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/03Animal model, e.g. for test or diseases
    • A01K2267/0306Animal model for genetic diseases
    • A01K2267/0312Animal model for Alzheimer's disease
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00991290T 1999-12-28 2000-12-28 Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit ATE307904T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99403304A EP1113081A1 (de) 1999-12-28 1999-12-28 Zusammenhang des bekannten Gens CP2/LSF/LBP-1 mit Alzheimer
PCT/EP2000/013408 WO2001048240A2 (en) 1999-12-28 2000-12-28 Implication of a known gene named cp2/lsf-lbp-1 in alzheimer's desease

Publications (1)

Publication Number Publication Date
ATE307904T1 true ATE307904T1 (de) 2005-11-15

Family

ID=8242236

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00991290T ATE307904T1 (de) 1999-12-28 2000-12-28 Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit

Country Status (7)

Country Link
US (1) US20030190631A1 (de)
EP (2) EP1113081A1 (de)
JP (1) JP2003518390A (de)
AT (1) ATE307904T1 (de)
AU (1) AU3165901A (de)
DE (1) DE60023550D1 (de)
WO (1) WO2001048240A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9408465D0 (en) * 1994-04-27 1994-06-22 Univ Mcgill Apolipoprotein e polymorphism & treatment of alzheimer's disease
AU6435698A (en) * 1997-02-20 1998-09-09 Johns Hopkins School Of Medicine, The Control of (il4) production as a therapeutic regulator of immune function
FR2765591B1 (fr) * 1997-07-01 2002-08-09 Pasteur Institut Procede de diagnostic de la maladie d'alzheimer

Also Published As

Publication number Publication date
EP1242629B1 (de) 2005-10-26
US20030190631A1 (en) 2003-10-09
DE60023550D1 (de) 2005-12-01
EP1242629A2 (de) 2002-09-25
JP2003518390A (ja) 2003-06-10
WO2001048240A3 (en) 2001-12-06
EP1113081A1 (de) 2001-07-04
AU3165901A (en) 2001-07-09
WO2001048240A2 (en) 2001-07-05

Similar Documents

Publication Publication Date Title
FR18C1021I2 (fr) Methode de regulation de l'activite d'une molecule immunologiquement fonctionnelle
AU8448301A (en) Remedies for heart failure
CY1112261T1 (el) Μεσο για τον προσδιορισμο του προφιλ κινδυνου ενος ατομου για την αθηροσκληρωτικη νοσο
IL153052A0 (en) Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
NO931889D0 (no) Protease og beslektede dna-forbindelser
DZ2557A1 (fr) Appareil pour la production de courant de parcelles à haute vélocité.
EP1272905A4 (de) Verfahren und vorrichtung zum kompensieren einer dunkelverschiebung während der lebensdauer einer elektrofotografischen druckerpatrone
IL124728A0 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
ATE487737T1 (de) 32 humane sekretierte proteine
ATE295423T1 (de) Phosphodiesterase 8
NO974322L (no) DNA som koder for human papillomvirus type 18
ATE307904T1 (de) Zusammenhang des bekannten gens cp2/lsf/lbp-1 mit der alzheimerschen krankheit
PL330014A1 (en) Application of genetic modification of the gene of human protein g subjunit beta3 in diagnosing diseases
ATE230796T1 (de) Obesitätsphänotyp erzeugendes gen
AU2001270377A1 (en) Transgenic animal model of neurodegenerative disorders
ZA98656B (en) Lage-1 tumer associated nucleic acids
DE602005019540D1 (de) Diagnostische und therapeutische verwendung des mal2-gens und proteins bei neurodegenerativen krankheiten
ATE348109T1 (de) Das gen prv-1 und dessen verwendung
DE50311090D1 (de) Repressor der skelettmuskeldifferenzierung, dafür kodierende nucleinsäure und dessen verwendung in diagnostik und therapie
ATE247467T1 (de) Neue therapeutische verwendung von 1,6-dimethyl- 8beta-hydroxymethyl-10alpha-methoxyergolin
DK0771786T3 (da) Fremstilling af aryl- og vinylnitriler

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties